Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
Barzegar Behrooz, A.; Talaie, Z.; Jusheghani, F.; Łos, M.J.; Klonisch, T.; Ghavami, S. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma. Int. J. Mol. Sci. 2022, 23, 1353. https://doi.org/10.3390/ijms23031353
Barzegar Behrooz A, Talaie Z, Jusheghani F, Łos MJ, Klonisch T, Ghavami S. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma. International Journal of Molecular Sciences. 2022; 23(3):1353. https://doi.org/10.3390/ijms23031353
Chicago/Turabian StyleBarzegar Behrooz, Amir, Zahra Talaie, Fatemeh Jusheghani, Marek J. Łos, Thomas Klonisch, and Saeid Ghavami. 2022. "Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma" International Journal of Molecular Sciences 23, no. 3: 1353. https://doi.org/10.3390/ijms23031353